EVALUATION OF A MONOCLONAL ANTIBODY
$369,715N01FY2023AINIH
Dynport Vaccine Company, Llc, Frederick MD
Investigators
Abstract
The Biopharmaceutical Product Development Services program provides services to facilitate preclinical development of materials that are derived from biotechnology processes.
View original record on NIH RePORTER →